Suppression of intestinal mucosal apoptosis by ghrelin in fasting rats

Experimental Biology and Medicine

Volumn 233, Issue 1, 2008, Pages 48-56

  Jae, Myung Park ^a,b   Kakimoto, Takashi ^b   Kuroki, Tsukasa ^b   Shiraishi, Ryosuke ^b   Fujise, Takehiro ^b   Iwakiri, Ryuichi ^b   Fujimoto, Kazuma ^b  

^a The Catholic University of Korea   (South Korea)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Intraperitoneal infusion; Small intestine; Vagotomy

Indexed keywords

BROXURIDINE; CASPASE 3; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; GHRELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN THIRD VENTRICLE; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; ENZYME ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE VILLUS; MALE; NICK END LABELING; NONHUMAN; OSMOTIC PUMP; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMALL INTESTINE MUCOSA; TRUNCUS VAGOTOMY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DNA FRAGMENTATION; FASTING; GHRELIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTESTINAL MUCOSA; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 37549043548     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0706-RM-169     Document Type: Article

References (47)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999.
2. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 85:495-522, 2005.
3. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29, 1997.
4. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991, 2002.
5. Muccioli G, Tschöp M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440:235-254, 2002.
6. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977, 1996.
7. Tritos NA, Kokkotou EG. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc 81:653-660, 2006.
8. Dornonville de la Cour C, Lindström E, Norlén P, Håkanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 120:23-32, 2004.
9. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276:905-908, 2000.
10. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280:904-907, 2001.
11. Shiotani A, Miyanishi T, Uedo N, Iishi H. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 10:373-378, 2005.
12. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992-5995, 2001.
13. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547, 2001.
14. Traebert M, Riediger T, Whitebread S, Scharrer E, Schmid HA. Ghrelin acts on leptin-responsive neurons in the rat arcuate nucleus. J Neuroendocrinol 14:580-586, 2002.
15. Fujise T, Iwakiri R, Wu B, Amemori S, Kakimoto T, Yokoyama F, Sakata Y, Tsunada S, Fujimoto K. Apoptotic pathway in the rat small intestinal mucosa is different between fasting and ischemia-reperfusion. Am J Physiol 291:G110-G116, 2006.
16. Iwakiri R, Gotoh Y, Noda T, Sugihara H, Fujimoto K, Fuseler J, Aw TY. Programmed cell death in rat intestine: effect of feeding and fasting. Scand J Gastroenterol 36:39-47, 2001.
17. Utsumi H, Iwakiri R, Wu B, Fujise T, Sakata H, Shimoda R, Amemori S, Tsunada S, Ootani A, Fujimoto K. Intracerebroventricular administration of leptin-induced apoptosis in the rat small intestinal mucosa. Exp Biol Med 228:1239-1244, 2003.
18. Tolle V, Bassant MH, Zizzari P, Poindessous-Jazat F, Tomasetto C, Epelbaum J, Bluet-Pajot MT. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143:1353-1361, 2002.
19. Edholm T, Levin F, Hellström PM, Schmidt PT. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 121:25-30, 2004.
20. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130:1707-1720, 2006.
21. Sakata H, Ootani A, Fujise T, Sakata Y, Wu B, Tsunada S, Iwakiri R, Fujimoto K, Shiraishi T. Decreased apoptosis and increased ornithine decarboxylase activity in the intestinal mucosa of rats with bilateral ventromedial hypothalamus lesions. J Gastroenterol 40: 137-142, 2005.
22. Tanaka J, Fujimoto K, Sakata T, Fujimoto T, Tsunada S, Iwakiri R, Yamaguchi M, Okabe Y, Yoshimatsu H. Effect of vagotomy on ornithine decarboxylase activity in rat duodenal mucosa. Am J Physiol 265:G1016-G1020, 1993.
23. Lin T, Sakata H, Ootani A, Fujise T, Tsunada S, Amemori S, Danjo A, Yokoyama F, Sakata Y, Iwakiri R, Toda S, Fujimoto K. Apoptosis in rat jejunal mucosa is regulated partly through the central nervous system, which controls feeding behavior. J Gastroenterol Hepatol 20:1285-1291, 2005.
24. Wu B, Fujise T, Iwakiri R, Ootani A, Amemori S, Tsunada S, Toda S, Fujimoto K. Venous congestion induces mucosal apoptosis via tumor necrosis factor-α-mediated cell death in the rat small intestine. J Gastroenterol 39:1056-1062, 2004.
25. Aw TY, Nicotera P, Manzo L, Orrenius S. Tributyltin stimulates apoptosis in rat thymocytes. Arch Biochem Biophys 283:46-50, 1990.
26. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous activation. Nature 284:555-556, 1980.
27. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323, 1956.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992.
29. Tang Y, Swartz-Basile DA, Swietlicki EA, Yi L, Rubin DC, Levin MS. Bax is required for resection-induced changes in apoptosis, proliferation, and members of the extrinsic cell death pathways. Gastroenterology 126:220-230, 2004.
30. Hotter G, Closa D, Prados M, Fernández-Cruz L, Prats N, Gelpí E, Roselló-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 222:27-32, 1996.
31. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719, 2001.
32. Tschöp M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24:RC19-RC21, 2001.
33. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, Callahan HS, Purnell JQ. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 88:1577-1586, 2003.
34. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000.
35. Dowling RH. Small bowel adaptation and its regulation. Scand J Gastroenterol 74:53-74, 1982.
36. Guarino A, Canani RB, Iafusco M, Casola A, Russo R, Rubino A. In vivo and in vitro effects of human growth hormone on rat intestinal ion transport. Pediatr Res 37:576-580, 1995.
37. Scolapio JS. Short bowel syndrome: recent clinical outcomes with growth hormone. Gastroenterology 130:S122-S126, 2006.
38. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337-345, 2001.
39. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128, 2002.
40. le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA, Theodorou NA, Bloom SR. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90:4521-4524, 2005.
41. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 26:11052-11060, 2006.
42. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57-66, 2004.
43. Alexandrides T, Spiliotis J, Mylonas P, Melachrinou M, Kardamakis D, Spiliopoulou I, Panagopoulos C, Kalfarentzos F. Effects of growth hormone and insulin-like growth factor-I on radiation enteritis. A comparative study. Eur Surg Res 30:305-311, 1998.
44. Gómez-de-Segura IA, Prieto I, Grande AG, García P, Guerra A, Mendez J, De Miguel E. Growth hormone reduces mortality and bacterial translocation in irradiated rats. Acta Oncol 37:179-185, 1998.
45. Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC. Insulin-like growth factor-I (IGF-1) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15:279-292, 1998.
46. Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, Hisatomi A, Ozaki I, Yamamoto K, Kitajima Y, Kawaguchi Y, Kuroki S, Ono N. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 41:462-469, 2006.
47. Petschow BW, Carter DL, Hutton GD. Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats. J Pediatr Gastroenterol Nutr 17:49-58, 1993.